Valuation: Vistin Pharma ASA

Market Cap 887M 92.57M 81.3M 75.61M 69.38M 130M 8.91B 132M 898M 351M 4.38B 348M 340M 15.15B P/E 2024
16.7x
P/E 2025 12.3x
Enterprise Value 872M 91.01M 79.94M 74.34M 68.22M 128M 8.76B 130M 883M 345M 4.31B 342M 334M 14.9B EV / Sales 2024
2.42x
EV / Sales 2025 2.01x
Free-Float
41.06%
Yield 2024
5.27%
Yield 2025 7.21%
1 day-2.44%
1 week-2.91%
Current month-2.91%
1 month-2.91%
3 months-9.91%
6 months-4.31%
Current year-3.85%
1 week 20
Extreme 20
20.6
1 month 20
Extreme 20
20.7
Current year 20
Extreme 20
23.5
1 year 19.4
Extreme 19.4
25.3
3 years 19.4
Extreme 19.4
28.8
5 years 11.25
Extreme 11.25
28.8
10 years 5
Extreme 5
29.45
Manager TitleAgeSince
Chief Executive Officer - 2023-12-31
Director of Finance/CFO - 2020-03-01
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 54 2018-05-07
Director/Board Member - 2016-12-31
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/18/23 BuyCompany 100,000 0.2255%
5/31/23 Buy

Chief Executive Officer

15,000 0.0338%
5/30/23 Buy

Director

250,000 0.5638%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-2.91%-17.01%-15.97% 92.57M
-0.66%+0.44%+14.72%+76.40% 48.36B
+2.20%+1.41%+61.04%+111.43% 35.8B
+1.26%-0.57%-5.20%+34.48% 11.83B
-0.46%-3.06%+14.15%+80.63% 11.48B
-0.37%-0.37%+37.89%+137.78% 9.01B
+1.52%+0.39%+48.79%-5.82% 6.99B
-0.17%-2.92%+13.13%+30.45% 6.7B
-0.59%-1.95%+2.23%+178.07% 6.42B
-7.92%-13.61%-34.97%-4.08% 5.3B
Average -0.76%-2.20%+13.48%+62.34% 14.2B
Weighted average by Cap. +0.12%-0.45%+25.32%+81.30%

Financials

2024 2025
Net sales 430M 44.83M 39.37M 36.62M 33.6M 63.13M 4.32B 64.11M 435M 170M 2.12B 168M 165M 7.34B 452M 47.21M 41.46M 38.56M 35.38M 66.48M 4.55B 67.51M 458M 179M 2.24B 177M 173M 7.73B
Net income 62.75M 6.55M 5.75M 5.35M 4.91M 9.22M 631M 9.37M 63.52M 24.82M 310M 24.59M 24.06M 1.07B 74.75M 7.8M 6.85M 6.37M 5.85M 10.99M 751M 11.16M 75.67M 29.57M 369M 29.29M 28.66M 1.28B
Net Debt -10.55M -1.1M -967K -899K -825K -1.55M -106M -1.57M -10.68M -4.17M -52.13M -4.13M -4.04M -180M -14.91M -1.56M -1.37M -1.27M -1.17M -2.19M -150M -2.23M -15.09M -5.9M -73.67M -5.84M -5.72M -255M
Logo Vistin Pharma ASA
Vistin Pharma ASA is a Norway-based holding company, which operates through its subsidiary Vistin Pharma AS. The Company is engaged in the pharmaceuticals industry. The Company is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
Employees
76
Date Price Change Volume
26-07-24 NOK 20.00 -2.44% 800
26-07-23 NOK 20.50 0.00% 4,292
26-07-22 NOK 20.50 +2.50% 776
26-07-21 NOK 20.00 -1.48% 9,330
26-07-20 NOK 20.30 -1.46% 6,992
  1. Stock Market
  2. Stocks
  3. VISTN Stock